Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
1 Division of Cellular and Molecular Biology, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan. 2 Department of Integrated Biosciences, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Chiba 277-8562, Japan. 3 Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama, Toyama 930-0194, Japan. 4 Laboratory of Immune Regulation, Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan. 5 Laboratory of Host Defense, Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan. 6 Department of Drug Metabolism and Disposition, Graduate School of Pharmaceutical Sciences, Nagoya City University, Mizuho-ku, Nagoya 467-8603, Japan. 7 Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520–8089, USA.
* Present address: Department of Global Infectious Diseases and Tropical Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Abstract:
The cytokine interleukin-1 (IL-1) mediates immune and inflammatory responses by activating the transcription factor nuclear factor B (NF-B). Although transforming growth factor–β–activated kinase 1 (TAK1) and mitogen-activated protein kinase (MAPK) kinase kinase 3 (MEKK3) are both crucial for IL-1–dependent activation of NF-B, their potential functional and physical interactions remain unclear. Here, we showed that TAK1-mediated activation of NF-B required the transient formation of a signaling complex that included tumor necrosis factor receptor–associated factor 6 (TRAF6), MEKK3, and TAK1. Site-specific, lysine 63–linked polyubiquitination of TAK1 at lysine 209, likely catalyzed by TRAF6 and Ubc13, was required for the formation of this complex. After TAK1-mediated activation of NF-B, TRAF6 subsequently activated NF-B through MEKK3 independently of TAK1, thereby establishing continuous activation of NF-B, which was required for the production of sufficient cytokines. Therefore, we propose that the cooperative activation of NF-B by two mechanistically and temporally distinct MEKK3-dependent pathways that diverge at TRAF6 critically contributes to immune and inflammatory systems.
To whom correspondence should be addressed. E-mail: jun-i{at}ims.u-tokyo.ac.jp
Citation: K. Yamazaki, J. Gohda, A. Kanayama, Y. Miyamoto, H. Sakurai, M. Yamamoto, S. Akira, H. Hayashi, B. Su, J.-i. Inoue, Two Mechanistically and Temporally Distinct NF-B Activation Pathways in IL-1 Signaling. Sci. Signal.2, ra66 (2009).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
PERSPECTIVES
Bahram Razani and Genhong Cheng (7 September 2010) Sci. Signal.3 (138), pe29.
[DOI: 10.1126/scisignal.3138pe29] |Abstract »|Full Text »|PDF »
EDITORIAL GUIDES
John F. Foley and Nancy R. Gough (19 January 2010) Sci. Signal.3 (105), eg2.
[DOI: 10.1126/scisignal.3105eg2] |Abstract »|Full Text »|PDF »
PERSPECTIVES
Shelly M. Wuerzberger-Davis and Shigeki Miyamoto (19 January 2010) Sci. Signal.3 (105), pe3.
[DOI: 10.1126/scisignal.3105pe3] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Polyubiquitination of Transforming Growth Factor {beta} (TGF{beta})-associated Kinase 1 Mediates Nuclear Factor-{kappa}B Activation in Response to Different Inflammatory Stimuli.
A. Hamidi, V. von Bulow, R. Hamidi, N. Winssinger, S. Barluenga, C.-H. Heldin, and M. Landstrom (2012)
J. Biol. Chem.
287, 123-133
|Abstract »|Full Text »|PDF »
TAK1 in brain endothelial cells mediates fever and lethargy.
D. A. Ridder, M.-F. Lang, S. Salinin, J.-P. Roderer, M. Struss, C. Maser-Gluth, and M. Schwaninger (2011)
J. Exp. Med.
208, 2615-2623
|Abstract »|Full Text »|PDF »
Activation of the I{kappa}B kinase complex by HTLV-1 Tax requires cytosolic factors involved in Tax-induced polyubiquitination.
Y. Shibata, Y. Tanaka, J. Gohda, and J.-i. Inoue (2011)
J. Biochem.
150, 679-686
|Abstract »|Full Text »|PDF »
Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1.
D. Melisi, Q. Xia, G. Paradiso, J. Ling, T. Moccia, C. Carbone, A. Budillon, J. L. Abbruzzese, and P. J. Chiao (2011)
J Natl Cancer Inst
103, 1190-1204
|Abstract »|Full Text »|PDF »
MEKK3 Regulates IFN-{gamma} Production in T Cells through the Rac1/2-Dependent MAPK Cascades.
X. Wang, F. Zhang, F. Chen, D. Liu, Y. Zheng, Y. Zhang, C. Dong, and B. Su (2011)
J. Immunol.
186, 5791-5800
|Abstract »|Full Text »|PDF »
The Critical Role of IL-1 Receptor-Associated Kinase 4-Mediated NF-{kappa}B Activation in Modified Low-Density Lipoprotein-Induced Inflammatory Gene Expression and Atherosclerosis.
T. W. Kim, M. Febbraio, P. Robinet, B. DuGar, D. Greene, A. Cerny, E. Latz, R. Gilmour, K. Staschke, G. Chisolm, et al. (2011)
J. Immunol.
186, 2871-2880
|Abstract »|Full Text »|PDF »
H. H. Cheung, S. T. Beug, M. St. Jean, A. Brewster, N. L. Kelly, S. Wang, and R. G. Korneluk (2010)
J. Biol. Chem.
285, 40612-40623
|Abstract »|Full Text »|PDF »
Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology.
J. Gautheron, A. Pescatore, F. Fusco, E. Esposito, S. Yamaoka, F. Agou, M. V. Ursini, and G. Courtois (2010)
Hum. Mol. Genet.
19, 3138-3149
|Abstract »|Full Text »|PDF »
A. L. Borikova, C. F. Dibble, N. Sciaky, C. M. Welch, A. N. Abell, S. Bencharit, and G. L. Johnson (2010)
J. Biol. Chem.
285, 11760-11764
|Abstract »|Full Text »|PDF »